COMMUNIQUÉS West-GlobeNewswire

Rad Source Technologies Introduces Sterile Insect Farms™
10/09/2026
Now offering Sterile Mosquitoes for Non-Chemical & Non-GMO Vector Control BUFORD, Ga., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Rad Source Technologies, a leading innovator in X-ray solutions for life sciences, is proud [...]
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
10/09/2026
Company announcement – No. 47 / 2026 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, September 10, 2026 – Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ: [...]
Adneuris Therapeutics Presents Novel Data on Lead Candidate, Cebranopadol for the Treatment of Moderate-to-Severe Acute Pain at PAINWeek 2026
10/09/2026
Adneuris unveiled new abuse potential data demonstrating that cebranopadol's abuse potential may be lower than that of Schedule II and Schedule IV pain drugs, further differentiating its dual NOP/MOP mechanism from [...]
electroCore to Participate at H.C. Wainwright Global Investment Conference
10/09/2026
ROCKAWAY, N.J., Sept. 10, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the H.C. [...]
Senseonics To Participate in Upcoming Institutional Investor Conferences
10/09/2026
GERMANTOWN, Md., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose [...]
Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting
10/09/2026
-- Real-world data showed reductions in BMI with up to 18 months of setmelanotide therapy in 30 paediatric patients with acquired hypothalamic obesity (HO) in France – -- Phase 3 analyses demonstrated improvements [...]
ApolloMD Welcomes Scott O’Neil to Strategic Advisory Board
10/09/2026
Healthcare executive joins board as ApolloMD brings industry leaders together to explore the future of healthcare ATLANTA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- ApolloMD, a clinician-owned and clinician-led multispecialty [...]
Legend Biotech to Present Updated Long-Term and Real-World Evidence from CARVYKTI Clinical Program at the International Myeloma Society Annual Meeting
10/09/2026
Updated long-term follow-up data will be presented from CARTITUDE-2 Cohort A in patients with lenalidomide-refractory multiple myeloma after 1-3 prior lines of therapy Real-world evidence and post-authorization safety [...]
Humacyte to Present at the H.C. Wainwright 28th Annual Global Investment Conference
10/09/2026
DURHAM, N.C., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, [...]
Electra Therapeutics Announces Initiation of a Phase 1 Trial of ELA822, a Novel SIRPγ-Specific Antibody Designed to Treat T Cell-Mediated Immune and Inflammatory Diseases
10/09/2026
Second clinical-stage asset generated from the company’s proprietary library of SIRP-targeted antibodies SOUTH SAN FRANCISCO, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Electra Therapeutics, a clinical-stage [...]
Erasca Announces Multiple Presentations at the Upcoming 38th EORTC-NCI-AACR Symposium
10/09/2026
Oral presentation to share updated monotherapy clinical data for ERAS-0015 including additional patients and longer follow-up, expanding on the previously reported preliminary results from the ongoing AURORAS-1 Phase 1 [...]
Cannara étend son financement à une facilité de crédit syndiquée de 80 millions de dollars auprès de BMO et de la Banque TD, renforçant ainsi davantage ses bases financières pour poursuivre sa croissance
10/09/2026
Cette nouvelle structure de financement offre une plus grande souplesse financière grâce à une facilité de crédit renouvelable portée à 40 millions de dollars, à une réduction des coûts d’emprunt et à une prolongation [...]
Cannara Expands Financing to an $80 Million Syndicated Credit Facility with BMO and TD Bank, Further Strengthening Its Financial Foundation for Continued Growth
10/09/2026
The new financing structure provides greater financial flexibility through an expanded $40 million revolving credit facility, reduced borrowing costs and an extended maturity to December 31, 2029 MONTREAL, Sept. 10, [...]
Biora Therapeutics to Initiate First Human Trial of BioJet™ Oral Biologic Delivery Capsule
10/09/2026
Healthy volunteer study will evaluate ingestible delivery capsule for oral, needle-free administration of adalimumab with topline data expected by early 2027 SAN DIEGO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Biora [...]
IN8bio to Present at H.C. Wainwright 28th Annual Global Investment Conference
10/09/2026
NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies and T cell engagers for cancer and autoimmune [...]
Galectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
10/09/2026
NORCROSS, Ga., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that company management will present and [...]
BGI Group Showcases New Technologies for Advancing Personalized Health at 2026 Global New Product Launch Event
10/09/2026
SHENZHEN, China, Sept. 10, 2026 (GLOBE NEWSWIRE) -- On September 9, BGI Group held its 2026 Global New Product Launch Event at BGI Center in Shenzhen, marking the organization’s 27th anniversary. Under the theme “ [...]
Adagene Announces that Third Arc Bio Has Selected First Lead Candidate under Amended Strategic Collaboration for Development of Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology
10/09/2026
Amended terms of agreement include a transition to an integrated asset and technology partnership. SAN DIEGO and SUZHOU, China, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform- [...]
ORYZON to Participate in Upcoming Events in September and October
10/09/2026
MADRID and CAMBRIDGE, Mass., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and global leader in epigenetics, announced today that its [...]

Pages